James is head of Mills & Reeve's fast growing multi-disciplinary life sciences team.
England - East Anglia • TMT (technology, media and telecoms)
Mills & Reeve LLP
In Cambridge, Mills & Reeve LLP houses a multi-disciplinary life sciences practice that advises on transactional issues, patents and IP, and privacy. The 'excellent' James Fry leads the team, and acted for GSK on the spin-off of its consumer health business Haleon plc, having a great deal of expertise in IP licensing and distribution. Fry also notably acts for F-star Therapeutics and NRG Therapeutics. Funds specialist Dona Ardeman, corporate partner Jonathan Greenwood , employment adviser Melanie James and corporate finance expert Zickie Lim are among the key contacts for biotechnology clients.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'Very commercially minded, easy to work with, very flexible and capable.'
- 'James Fry is an excellent lawyer.'
Key clients
- GSK
- PhoreMost
- F-star Therapeutics
- Calypso Biotech
- Sapphiros
- NRG Therapeutics
- Neurocrine Biosciences
- Kadans Science Partners
- Kadans Science Partners
Work highlights
- Advised GSK on the divestment of Haleon plc. The firm assisted with the cloning and renegotiation of hundreds of commercial contracts, ensuring that the new business has continuing supplier arrangements to support it from day 1 of its operation.
- Advised F-star on its licence and collaboration agreement with Takeda. The agreement which grants licences to Takeda of F-star’s proprietary platform IP relating to the generation of bi-specific antibodies will facilitate research towards the development of a next generation immuno-oncology bispecific antibody.
- Acted for NRG Therapeutics on its Series A fundraising led by Omega Funds and also including Brandon Capital.
Lawyers
Leading individuals
Practice head
The lawyer(s) leading their teams.
James Fry